Gelesis Holdings, Inc. (GLS) |
0.18 0.01 (5.88%)
|
03-27 16:00 |
Open: |
0.1785 |
Pre. Close: |
0.17 |
High:
|
0.18 |
Low:
|
0.1502 |
Volume:
|
723,808 |
Market Cap:
|
13(M) |
|
|
Technical analysis |
as of: 2023-03-27 4:19:42 PM |
Overall:
|
|
Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
Target: |
Six months: 0.28 One year: 0.38  |
Support: |
Support1: 0.1 Support2: 0.09 |
Resistance: |
Resistance1: 0.24 Resistance2: 0.32  |
Pivot: |
0.19  |
Moving Average: |
MA(5): 0.16 MA(20): 0.21 
MA(100): 0.3 MA(250): 1.58  |
MACD: |
MACD(12,26): -0.1 Signal(9): -0.1  |
Stochastic oscillator: |
%K(14,3): 34.6 %D(3): 29.6  |
RSI: |
RSI(14): 42.6  |
52-week: |
High: 5.94 Low: 0.1 |
Average Vol(K): |
3-Month: 376 (K) 10-Days: 1,219 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ GLS ] has closed above bottom band by 38.8%. Bollinger Bands are 25.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
0.17 - 0.17 |
0.17 - 0.17 |
Low:
|
0.14 - 0.14 |
0.14 - 0.14 |
Close:
|
0.17 - 0.17 |
0.17 - 0.17 |
|
Company Description |
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts. |
Headline News |
Fri, 24 Mar 2023 Markets Today: Stock Indexes Slump on Banking Sector Woes - Barchart
Fri, 24 Mar 2023 North American Morning Briefing : Stock Futures -2- - Marketscreener.com
Wed, 22 Mar 2023 Why GameStop Shares Are Trading Higher By Around 44%; Here ... - Investing.com UK
Tue, 21 Mar 2023 Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are ... - Investing.com UK
Tue, 21 Mar 2023 Where Will Gelesis Holdings Inc (GLS) Stock Go Next After It Has Fallen 31.82% in a Week? - InvestorsObserver
Tue, 21 Mar 2023 Real-Time Update: Gelesis Holdings Inc. (GLS) Stock Navigates the ... - The News Heater
|
Financial Analysis |
Price to Book Value: |
Underperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Underperform |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Outperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Underperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NYSE |
Sector: Healthcare |
Industry: Biotechnology |
Shares Out. |
73 (M) |
Shares Float |
20 (M) |
% Held by Insiders
|
52.2 (%) |
% Held by Institutions
|
32.8 (%) |
Shares Short
|
513 (K) |
Shares Short P.Month
|
712 (K) |
Stock Financials |
EPS
|
-1.34 |
EPS Est Next Qtl
|
0 |
EPS Est This Year
|
0 |
EPS Est Next Year
|
0 |
Book Value (p.s.)
|
-0.06 |
Profit Margin (%)
|
-198.5 |
Operating Margin (%)
|
-443.7 |
Return on Assets (ttm)
|
-51.8 |
Return on Equity (ttm)
|
-552.4 |
Qtrly Rev. Growth
|
120.6 |
Gross Profit (p.s.)
|
0.01 |
Sales Per Share
|
0.35 |
EBITDA (p.s.)
|
-1.51 |
Qtrly Earnings Growth
|
0 |
Operating Cash Flow
|
-90 (M) |
Levered Free Cash Flow
|
-82 (M) |
Stock Valuations |
PE Ratio
|
-0.14 |
PEG Ratio
|
0 |
Price to Book value
|
-3.59 |
Price to Sales
|
0.5 |
Price to Cash Flow
|
-0.15 |
Stock Dividends |
Dividend
|
0 |
Forward Dividend
|
0 |
Dividend Yield
|
0% |
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
Your Ad Here
|
|